BI 1820237
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BI 1820237, covering 2025-01-22 to 2025-03-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity [Phase 1]